ULTRALIFE CORP — Director's Dealing 2022

Dec 16, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2022-11-22

Reporting Person: Manna Michael Edward (Director, President and CEO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock; $.10 par value	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock (Right to Buy)	$4.2902	2023-06-01	Common Stock (10000)		Direct
Common Stock (Right to Buy)	$5.3057	2024-01-18	Common Stock (20000)		Direct
Common Stock (Right to Buy)	$9.8514	2025-04-18	Common Stock (8500)		Direct
Common Stock (Right to Buy)	$8.2523	2026-07-23	Common Stock (10000)		Direct
Common Stock (Right to Buy)	$8.4476	2026-09-06	Common Stock (10000)		Direct
Common Stock (Right to Buy)	$6.5062	2027-04-20	Common Stock (11000)		Direct
Common Stock (Right to Buy)	$6.9694	2028-10-20	Common Stock (12500)		Direct
Common Stock (Right to Buy)	$5.4533	2029-10-19	Common Stock (12500)		Direct

Footnotes

F1: Options vest in three equal installments on each of the first, second and third anniversaries of the date of issuance and expire seven years after the date of issuance.